Chinavestor.com for Professional Chinese Stocks Investment Advice" />
Document in the HKEx website - click here
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock company incorporated in the People’s Republic of China with limited liability)
(Stock Code: 2628)
2008 Third Quarter Report
This announcement is made by China Life Insurance Company Limited (the “Company”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
The financial data of the Company for the third quarter of 2008 are unaudited and have been prepared in accordance with generally accepted accounting principles in People’s Republic of China.
1. IMPORTANT NOTICE
1.1 The Company’s Board of Directors, the Supervisory Committee, its Directors, Supervisors and Senior Management warrant that there are no false representations, misleading statement or material omissions in the 2008 third quarter report, and jointly and severally accept full responsibility for the authenticity, accuracy and completeness of the information contained in this report.
1.2 Of the thirteen directors of the Company who should have attended the board meeting, ten attended in person . The Chairman and Executive Director Mr. Yang Chao, Executive Directors Mr. Wan Feng, Mr. Lin Dairen, Ms. Liu Yingqi, Non-executive Directors Mr. Miao Jianmin, Mr. Shi Guoqing, Ms. Zhuang Zuojin, Independent Non-executive Directors Mr. Long Yongtu, Mr. Ma Yongwei and Mr. Ngai Wai Fung attended the meeting. Independent Non-executive Directors Mr. Sun Shuyi and Mr. Chau Tak Hay, Mr. Cai Rang took leave and gave written authorizations to Independent Non-executive Directors Mr. Ma Yongwei, Mr. Ngai Wai Fung and Mr. Long Yongtu respectively to act as their proxies to attend and vote in the meeting.
1.3 The Company’s 2008 third quarter financial report is unaudited.
1.4 Mr. Yang Chao, Chairman of the Company, Mr. Liu Jiade, Vice President in charge of financial affairs, Ms. Shiu Wai Chung, Chief Actuary and Mr. Yang Zheng, head of the Financial Department, confirm that the financial statements in the 2008 third quarter report are true and complete.
2.1 Major accounting data and financial indicators
(Currency: RMB)
As at
30 September
2008
31 December
2007
Increase /(decrease)
compared to
2007 (%)
Total assets
Shareholders’ equity
(excluding minority interest)
(million)
Net assets per share attributable to
shareholders of the Company 4.68 6.02 -22.30
For the nine months ended
30 September 2008
the same period of
Net cash flows from operating activities
119,822 98.3
Net cash flows per share from operating
activities
4.24 98.3
For the
reporting period
(from July to
September)
For the nine
months ended
Increase / (decrease)
Net profit attributable to shareholders
of the Company
Basic earnings per share 0.08 0.46 -46.91
Basic earnings per share after deducting
non-recurring items – 0.47 –
Diluted earnings per share 0.08 0.46 -46.91
Return on net assets
Return on net assets after deducting
non-recurring items
As at 30 September 2008, investment assets of the Company were RMB888,689 million. For the
nine months ended 30 September 2008, the investment yield was 3.15% (or 4.26% if annualized, the
annualized yield = (the investment yield for the nine months ended 30 September 2008/270)×365), the
policy surrender rate was 3.76%, and the growth rate of premiums earned was 57.64%.
3
RMB Million
Non-recurring items
Gains/(losses) on disposal of non-current assets -1
Net non-operating income and expenses other than
those mentioned above
-77
Effect of income tax expenses 20
Total -58
2.2 The total number of shareholders and the top ten holders of listed shares not subject to trading
restrictions as at the end of the reporting period
The total number of shareholders at
the end of the reporting period
Number of A share holders: 320,113
Number of H share holders: 36,714
Particulars of the top ten holders of listed shares not subject to trading restrictions
Name of shareholders (Full name)
Number of
listed shares not
subject to trading
restrictions held
as at the end of the
reporting period Type
HKSCC Nominees Limited 6,916,737,309 H Shares
Richbo Investment Limited 378,358,620 H Shares
State Development and Investment Co., Ltd. 49,800,000 A Shares
China National Investment & Guaranty Co., Ltd. 40,000,000 A Shares
ICBC-Lion Stock Securities Investment Fund 30,500,000 A Shares
China Everbright Bank Co. Ltd.-Everbright Pramerica
Qualification Core Securities Investment Fund
27,057,068 A Shares
ICBC-SSE50 ETF Securities Investment Fund 23,275,291 A Shares
ICBC-Southern Carefully Chosen Securities
Investment Fund
20,498,040 A Shares
China National Nuclear Corporation 20,000,000 A Shares
China Shipping (Group) Company 20,000,000 A Shares
China International Television Corporation 20,000,000 A Shares
4
3. SIGNIFICANT EVENTS
3.1 Particulars of, and reasons for, material changes in major accounting items and financial
indicators of the Company
√
(1) Changes in key financial indicators and its reasons
RMB million (unless otherwise stated)
Key Financial Indicator
Increase/
(decrease)
(%) Main reasons
Operating profit 12,803 28,909 -55.71 Significant decrease of investment
income and fair value gains/(losses)
resulting from the deep downturn of
capital market
Net profit attributable
to shareholders of the
Company
13,111 24,696 -46.91 Significant decrease of investment
(2) Material changes in major accounting items and its reasons
Held-for-trading
financial assets
12,772 25,110 -49.14 Sale of part of held-for-trading
Interest receivable 14,090 9,832 43.31 Increase in debt securities investment
Policy loans 8,190 5,944 37.79 Significant increase in policy loans
Debt investment project 9,250 1,200 670.83 Increase in “China Life AMC &
Tianjin Infrastructure Investment
Group Debt Investment Project”
Long-term equity
investment
8,643 6,452 33.96 Capital injection to China Life P&C
Company Limited
Benefits and claims
payable
6,395 4,059 57.55 Significant increase of insurance
business
5
Policyholder dividends
36,410 64,473 -43.53 Significant decrease of investment
as well as the decrease of unrealized
gains in available-for-sale financial
assets resulting from the deep
downturn of capital market
Reserves for long-term
health insurance
7,952 4,028 97.42 Significant increase of health insurance
Capital surplus reserve 58,170 97,369 -40.26 Significant decrease of unrealized
nine months
ended 30
September
Gross written premiums 248,595 158,645 56.70 Significant increase of insurance
Unearned premium
reserves
1,806 1,234 46.35 Increase of short-term insurance
business together with the reverse of
receivable of ceded unearned premium
reserves etc.
Fair value gains/(losses) -8,006 11,145 -171.83 The unrealized losses in held-fortrading
financial assets resulting from
the deep downturn of capital market
Foreign exchange losses -1,008 -582 73.20 Continuing appreciation of RMB
Insurance reserves 130,609 51,416 154.02 Significant increase of insurance
6
Policyholder dividends 2,357 21,629 -89.10 Significant decrease of investment
Brokerage and
commission fees
18,395 12,379 48.60 Significant increase of insurance
Impairment losses -8,730 -2,692 224.29 Impairment loss on available-for-sale
financial assets resulting from the deep
3.2 Explanation and analysis of significant events and their impacts and solutions
On 3 September 2008 (New York Time), the U.S. District Court for the Southern District of New
York (“New York Southern District Court”) granted the Defendants’ motion to dismiss the purported
securities class action brought against the Company and certain individuals (the “Defendants”). The
New York Southern District Court granted summary judgment dismissing the claims asserted by
purchasers who acquired the stock of the Company on the New York Stock Exchange or any other
exchange in the U.S., or Americans who purchased the Company’s stock anywhere, finding that
“there is no merit to any of these claims.” Claims by non-U.S. purchasers who acquired the stock
of the Company on The Stock Exchange of Hong Kong Limited were dismissed for lack of subject
matter jurisdiction. On 14 October 2008 (New York Time), plaintiffs filed a Notice of Appeal stating
their intention to appeal the order of New York Southern District Court granting Defendants’ motion
to dismiss the complaint to the Court of Appeals for the Second Circuit. No briefing schedule has yet
been set. The Company intends to continue vigorously defending the lawsuit.
3.3 Implementation of undertakings by the Company, its shareholders and effective controller
7
1. During the Company’s A shares Initial Public Offering, China Life Insurance (Group) Company,
the controlling shareholder of the Company, had undertaken that it would not, within 36 months
from the listing of the Company’s A shares, transfer or authorize others to manage any shares
of the Company that are directly or indirectly owned by it, nor would it allow the Company to
acquire such shares. During the reporting period, China Life Insurance (Group) Company has
strictly adhered to the above undertaking and has not breached the above undertaking.
2. Before the Company’s A shares Initial Public Offering (as at 30 November 2006), of the land use
rights titles injected into the Company by China Life Insurance (Group) Company, at the time
of the restructuring and establishment of the Company, formalities for change of titles have not
been completed for the land use rights in respect of 4 pieces of land with a total area of 10,421.12
square meters. Of the properties that were injected into the Company, formalities for change of
title have not been completed for 6 properties with a gross floor area of 8,639.76 square meters.
China Life Insurance (Group) Company undertook that it would, within one year from the date of
listing of the Company’s A shares, assist the Company in completing the formalities for change
of titles in respect of the 4 pieces of land and 6 properties mentioned above, failing which it will
bear any loss that may be suffered by the Company as a result of such defective titles. China Life
Insurance (Group) Company has strictly observed its undertaking. As at the end of the reporting
period, all changes of titles had been completed except for two properties and related lands of the
Shenzhen Branch of the Company. The Shenzhen Branch of the Company continues to use the
above properties and related lands and no other parties have made any challenges or presented
obstacles for the use of the properties and related lands.
3. China Life-CMG Life Assurance Company Ltd., a subsidiary of China Life Insurance (Group)
Company (“CLIC”), is a sino-foreign joint venture established on 4 July 2000 and owned as
to 51% by CLIC and as to 49% by CMG Group of Australia. The scope of operations of China
Life-CMG Life Assurance Company Ltd. is to conduct the following businesses (excluding
statutory insurance business) within the administrative district of Shanghai municipality and in
the provinces, autonomous regions and municipalities directly under the Central Government
where it has established branches: (1) insurance business such as life insurance, health insurance
and accident and casualty insurance; (2) re-insurance of the above insurance businesses. CLIC
has agreed that it will, within three years of the listing of the Company on The Stock Exchange
of Hong Kong Limited, dispose all of its interests in this joint venture to any third party or
otherwise eliminate any competition between China Life-CMG Life Assurance Company Ltd.
and the Company. The Company received written notice from CLIC that as of the end of the
reporting period, CLIC was working towards the transfer of its interest in China Life-CMG Life
Assurance Company Ltd. The Company will make timely disclosure according to the relevant
listing rule requirements of the place where the Company is listed.
3.4 Warnings and explanation for any significant changes in net profit or cumulative loss from the
beginning of the year to the end of the next reporting period as compared to the same period of
last year
Applicable
8
3.5 Securities Investment
No. Stock code Abbreviation
Number of shares
as at
Initial
cost
(RMB million)
Book value as at
31 December 2007
1 600030 CITIC Securities
5,792,964 23 143 N/A Held-for-trading financial assets
617,436,023 5,459 15,288 N/A Available-for-sale financial assets
2 600016 CMBC
233,496,562 748 1,205 N/A Held-for-trading financial assets
928,200,000 5,448 4,790 10,581 Available-for-sale financial assets
3 160706 Harvest 300 Fund
114,459,102 124 66 N/A Held-for-trading financial assets
4,953,113,079 2,713 2,858 N/A Available-for-sale financial assets
601398
ICBC
568,769,243 2,201 2,474 N/A Available-for-sale financial assets
HK1398 41,725,000 211 168 N/A Available-for-sale financial assets
601939
CCB
460,018,751 2,996 2,176 N/A Available-for-sale financial assets
HK0939 5,615,000 35 25 N/A Available-for-sale financial assets
601088
China Shenhua
55,173,499 2,081 1,511 N/A Available-for-sale financial assets
HK1088 2,191,500 71 36 N/A Available-for-sale financial assets
7 601006 Daqin Railway 113,263,273 808 1,461 N/A Available-for-sale financial assets
8 050002 Bosera Yufu Fund
6,881,768 8 4 N/A Held-for-trading financial assets
2,061,855,670 1,200 1,282 N/A Available-for-sale financial assets
9 110003 Efund SSE50 Fund
47,842,435 53 33 N/A Held-for-trading financial assets
1,766,300,703 1,200 1,201 N/A Available-for-sale financial assets
10 519300
Da Cheng SHSZ300
Fund
40,887,836 54 31 N/A Held-for-trading financial assets
1,244,515,781 1,000 941 N/A Available-for-sale financial assets
Total – 26,433 35,693 – –
Notes:
1. The securities investment in above table includes stocks, warrants, convertible debts of other listed companies and the
open/closed funds held by the Company, which are calculated as held-for-trading financial assets and available-for-sale
financial assets.
2. The top-ten securities investment is in order of the book value as at the end of the period.
3. If the securities were not held as at the beginning of the period or changes occurred during the period, thus leading to
the inability to accurately determine the amount of securities investment from the book values of the securities, the book
value as at 31 December 2007 could be N/A.
9
This announcement is published in both Chinese and English languages. The Chinese version
announcement shall prevail.
By Order of the Board of
China Life Insurance Company Limited
Heng Kwoo Seng
Company Secretary
As at the date of this announcement, the Board of Directors of the Company comprises:
Executive Directors:
Non-executive Directors:
Independent non-executive Directors:
Chau Tak Hay, Cai Rang, Ngai Wai Fung
Hong Kong, 27 October 2008
10
4. APPENDIX
4.1 Balance sheet as at 30 September 2008 (unaudited)
RMB million (Unless otherwise stated)
As at 30 As at 31 As at 30 As at 31
September December September December
2008 2007 2008 2007
ASSETS Group Group Company Company
Cash and cash equivalents 30,516 25,317 30,369 24,808
Held-for-trading financial assets 12,772 25,110 12,196 24,844
Securities purchased under
agreements to resell 1,985 5,053 1,985 4,673
Interest receivables 14,090 9,832 14,043 9,822
Premiums receivables 8,192 6,218 8,192 6,218
Receivable from reinsurers 166 72 166 72
Unearned premium reserves
receivable from reinsurers 59 474 59 474
Claim reserves receivable from reinsurers 19 167 19 167
Reserves for long-term health insurance
receivables from reinsurers 662 658 662 658
Policy loans 8,190 5,944 8,190 5,944
Debt plan investments 9,250 1,200 9,200 1,200
Other receivables 3,192 1,748 3,147 1,717
Term deposits 192,642 168,594 192,642 168,594
Available-for-sale financial assets 416,036 417,513 413,585 416,679
Held-to-maturity investments 211,145 195,703 211,145 195,703
Long-term equity investments 8,643 6,452 11,428 7,382
Statutory deposits 6,153 5,773 5,653 5,653
Fixed assets 15,665 15,332 15,331 14,988
Intangible assets 2,657 2,660 2,648 2,653
Deferred tax assets 2,997 – 2,959 –
Other assets 1,387 784 1,387 784
Total Assets 946,418 894,604 945,006 893,033
Yang Chao Liu Jiade Shiu Wai Chung Yang Zheng
Chairman Vice President in charge of Chief Actuary Head of
accounting affairs Financial Department
11
4.1 Balance sheet as at 30 September 2008 (unaudited) (continued)
LIABILITIES AND EQUITY Group Group Company Company
Liabilities
Assets sold under agreements to repurchase 5,100 100 5,100 100
Premiums received in advance 1,385 2,201 1,385 2,201
Brokerage and commission payable 1,231 1,134 1,231 1,131
Due to reinsurers 37 12 37 12
Salary and welfare payable 2,211 3,263 2,146 3,145
Taxes payable 1,470 9,051 1,443 8,990
Claims payable 6,395 4,059 6,395 4,059
Policyholder dividends payable 36,410 64,473 36,410 64,473
Other payables 1,999 3,173 2,020 3,145
Policyholder deposits and insurance
agency liabilities 1,780 1,944 1,780 1,944
Unearned premium reserves 7,510 6,119 7,510 6,119
Claim reserves 2,402 2,391 2,402 2,391
Reserves for life insurance 736,069 607,363 736,069 607,363
Reserves for long-term health insurance 7,952 4,028 7,952 4,028
Deferred tax liabilities – 13,024 – 12,981
Other liabilities 1,229 1,180 1,229 1,180
Total liabilities 813,180 723,515 813,109 723,262
Share capital 28,265 28,265 28,265 28,265
Capital reserves 58,170 97,369 58,249 97,297
Surplus reserves 9,280 6,488 9,232 6,440
General risk reserves 2,792 2,792 2,792 2,792
Retained earnings 33,747 35,299 33,359 34,977
Total equity attributable to
shareholders of the Company 132,254 170,213 131,897 169,771
Minority interests 984 876
Total shareholders’ equity 133,238 171,089 131,897 169,771
Total liabilities and shareholders’ equity 946,418 894,604 945,006 893,033
12
4.2 Income statement for the nine months ended 30 September 2008 (unaudited)
For the nine months For the nine months
ended 30 September ended 30 September
Group Group Company Company
1. Operating income 284,945 222,819 284,722 222,471
Earned premiums 247,139 156,772 247,139 156,772
Premiums income 248,595 158,645 248,595 158,645
Including: reinsurance premium income – 4 – 4
Less: premium ceded to reinsurers 350 (639) 350 (639)
Unearned premium reserves (1,806) (1,234) (1,806) (1,234)
Investment income 45,319 54,114 45,253 53,866
Including: income from associates 637 359 637 359
Fair value gains/(losses) (8,006) 11,145 (7,900) 11,125
Foreign exchange losses (1,008) (582) (1,004) (580)
Other operating income 1,501 1,370 1,234 1,288
2. Operating expenses (272,142) (193,910) (272,199) (194,015)
Surrenders (31,942) (33,953) (31,942) (33,953)
Claims paid (66,967) (58,763) (66,967) (58,763)
Less: claims recoverable from reinsurers 45 363 45 363
Insurance reserves (130,609) (51,416) (130,609) (51,416)
Less: insurance reserves recoverable
from reinsurers (144) (51) (144) (51)
Policyholder dividends (2,357) (21,629) (2,357) (21,629)
Reinsurance expenses – (4) – (4)
Business tax and surcharges (898) (1,777) (865) (1,757)
Brokerage and commission fees (18,395) (12,379) (18,395) (12,379)
Administrative expenses (11,284) (10,889) (11,107) (10,780)
Less: Expenses recoverable from reinsurers (58) 72 (58) 72
Other operating expenses (803) (792) (1,070) (1,026)
Impairment losses (8,730) (2,692) (8,730) (2,692)
3. Operating profit 12,803 28,909 12,523 28,456
Add: Non-operating income 20 24 20 24
Less: Non-operating expenses (98) (34) (94) (34)
4. Net profit before income tax expenses 12,725 28,899 12,449 28,446
Less: Income tax expenses 535 (4,044) 596 (3,931)
5. Net profit 13,260 24,855 13,045 24,515
6. Attributable to:
– shareholders of the Company 13,111 24,696
– minority interests 149 159
7. Earnings per share
Basic earnings per share 0.46 0.87
Diluted earnings per share 0.46 0.87
13
4.2 Income statement for the three months ended 30 September 2008 (unaudited) (continued)
For the three months For the three months
1. Operating income 76,973 60,811 77,081 60,743
Earned premiums 65,694 36,196 65,694 36,196
Premiums income 66,532 37,314 66,532 37,314
Including: reinsurance premium income – – – –
Less: premium ceded to reinsurers (32) (244) (32) (244)
Unearned premium reserves (806) (874) (806) (874)
Investment income 11,124 19,693 11,257 19,665
Including: income from associates 83 38 83 38
Fair value gains/(losses) (240) 4,686 (215) 4,676
Foreign exchange losses (28) (192) (28) (191)
Other operating income 423 428 373 397
2. Operating expenses (74,385) (51,837) (74,397) (51,868)
Surrenders (8,416) (12,469) (8,416) (12,469)
Claims paid (14,655) (9,282) (14,655) (9,282)
Less: claims recoverable from reinsurers 15 123 15 123
Insurance reserve (38,386) (11,714) (38,386) (11,714)
Less: insurance reserves recoverable from reinsurers – 4 – 4
Policyholder dividends (217) (9,233) (217) (9,233)
Reinsurance expenses – – – –
Business tax and surcharges (141) (570) (134) (564)
Brokerage and commission fees (5,554) (3,511) (5,554) (3,511)
Administrative expenses (3,562) (4,167) (3,508) (4,131)
Less: Expenses recoverable from reinsurers 12 (27) 12 (27)
Other operating expenses (378) (548) (451) (621)
Impairment losses (3,103) (443) (3,103) (443)
3. Operating profit 2,588 8,974 2,684 8,875
Add: Non-operating income 10 15 10 16
Less: Non-operating expenses (58) (14) (58) (14)
4. Net profit before income tax expenses 2,540 8,975 2,636 8,877
Less: Income tax expenses (184) (1,116) (168) (1,050)
5. Net profit 2,356 7,859 2,468 7,827
– shareholders of the Company 2,339 7,823
– minority interests 17 36
Basic earnings per share 0.08 0.27
Diluted earnings per share 0.08 0.27
14
4.3 Cash flow statement for the nine months ended 30 September 2008 (unaudited)
1. Cash flows from operating activities
Premium received 245,667 155,978 245,667 155,978
Net cash from reinsurance business 269 (19) 269 (19)
Net increase in policyholder investments – 253 – 253
Net cash from held-for-trading financial assets 19,350 22,324 19,659 22,573
Cash received from other operating activities 3,876 1,210 1,530 850
Sub-total of cash inflows from
operating activities 269,162 179,746 267,125 179,635
Cash paid for claims (96,557) (91,868) (96,557) (91,868)
Net decrease in policyholder investments (50) – (50) –
Cash paid for brokerage and commission fees (18,298) (12,511) (18,295) (12,511)
Cash paid for policyholder dividends (7,697) (3,883) (7,697) (3,883)
Cash paid to and for employees (7,026) (4,419) (6,286) (4,330)
Cash paid for taxes and surcharges (9,865) (2,688) (9,741) (2,520)
Cash paid for other operating activities (9,847) (3,952) (8,487) (4,163)
Sub-total of cash outflows from
operating activities (149,340) (119,321) (147,113) (119,275)
Net cash flows from operating activities 119,822 60,425 120,012 60,360
15
4.3 Cash flow statement for the nine months ended 30 September 2008 (unaudited) (continued)
2. Cash flows from investing activities
Cash received from sales
and redemption of investments 80,169 57,602 78,508 54,629
Cash received from investment income 38,942 26,059 38,843 25,766
Net cash received from disposals of fi xed assets,
intangible assets and other long-term assets 109 35 109 33
Net cash from securities purchased
under agreements to resell 2,977 – 2,774 –
investing activities 122,197 83,696 120,234 80,428
Cash paid for acquisition of investments (224,926) (149,090) (222,913) (146,169)
Net increase in policy loans (2,014) (2,509) (2,014) (2,509)
Cash paid for acquisition of fixed assets,
intangible assets and other long-term assets (1,719) (1,900) (1,700) (1,871)
Net cash paid for securities purchased under
agreements to resell – (20,287) – (20,149)
investing activities (228,659) (173,786) (226,627) (170,698)
Net cash flows from investing activities (106,462) (90,090) (106,393) (90,270)
16
3. Cash flows from financing activities
Cash received from capital contributions – 29 – –
financing activities 4,664 44,262 4,666 43,965
Net proceeds from investment in securities
sold under agreements to repurchase 4,664 44,291 4,666 43,965
Cash paid for dividends and interest (11,967) (3,999) (11,871) (3,957)
financing activities (11,967) (3,999) (11,871) (3,957)
Net cash flows from financing activities (7,303) 40,292 (7,205) 40,008
4. Effect of changes in foreign exchange
rate on cash and cash equivalents (858) (298) (853) (297)
5. Net increase/(decrease) in cash and
cash equivalents 5,199 10,329 5,561 9,801
Add: Opening balance of cash and
cash equivalents 25,317 50,213 24,808 49,735
6. Closing balance of cash and cash equivalents 30,516 60,542 30,369 59,536
Remember Me
Page rendered at 1/8/2009 6:34:49 AM (Eastern Standard Time, UTC-05:00)
Disclaimer The opinions expressed herein are my own personal opinions and do not represent my employer's view in anyway.